| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2139 | 2003 |
| Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. LJD Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d ... Lancet 352 (9142), 1725-30, 1998 | 1673 | 1998 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1520 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration CA Sabin, SW Worm, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ... Lancet 371 (9622), 1417, 2008 | 1199 | 2008 |
| Major Clinical Outcomes in Antiretroviral Therapy (ART)-Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study. Commentary MD HUGHES, HR RIBAUDO The Journal of Infectious Diseases 197 (8), 2008 | 585 | 2008 |
| Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ... Aids 24 (11), 1667-1678, 2010 | 547 | 2010 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 472 | 2010 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 430 | 2024 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber The Lancet 364 (9428), 51-62, 2004 | 393 | 2004 |
| Serious fatal and nonfatal non-AIDS-defining illnesses in Europe A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010 | 344 | 2010 |
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort … Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... International journal of epidemiology 41 (2), 433-445, 2012 | 323 | 2012 |
| Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study JP Viard, A Mocroft, A Chiesi, O Kirk, B Røge, G Panos, N Vetter, ... The Journal of infectious diseases 183 (8), 1290-1294, 2001 | 321 | 2001 |
| Worldwide prevalence of head lice ME Falagas, DK Matthaiou, PI Rafailidis, G Panos, G Pappas Emerging infectious diseases 14 (9), 1493-1494, 2008 | 296 | 2008 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 294 | 2005 |
| A meta-analysis of transient elastography for the detection of hepatic fibrosis J Stebbing, L Farouk, G Panos, M Anderson, LR Jiao, S Mandalia, ... Journal of clinical gastroenterology 44 (3), 214-219, 2010 | 284 | 2010 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 280 | 2024 |
| Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study E Florence, J Lundgren, C Dreezen, M Fisher, O Kirk, A Blaxhult, G Panos, ... HIV medicine 4 (3), 255-262, 2003 | 278 | 2003 |
| Inferior clinical outcome of the CD4 (+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4 (+) cell counts and HIV RNA levels … JD Lundgren, A Babiker, W El-Sadr, S Emery, B Grund, JD Neaton, ... Journal of Infectious Diseases 197 (8), 1145-1155, 2008 | 260 | 2008 |
| Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ... Aids 25 (10), 1305-1315, 2011 | 251 | 2011 |
| Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe V Soriano, A Mocroft, J Rockstroh, B Ledergerber, B Knysz, ... Journal of Infectious Diseases 198 (9), 1337-1344, 2008 | 215 | 2008 |
